Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
276.50
+2.29 (0.84%)
Apr 20, 2026, 4:00 PM EDT - Market closed

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Product Revenue, Net
389.13M290.52M
Product Revenue, Net Growth
33.95%473.02%
Revenue (Total)
389.13M290.52M
Revenue (Total) Growth
33.95%473.02%
Updated Feb 17, 2026. Data Source: Fiscal.ai.